Press Release - Uppsala Sweden
The KUBio "factory in a box" is expanding to accelerate the
accessibility of biotherapeutics on a global scale. Additional
modular platforms will be introduced in 2020 allowing biopharma
manufacturers to quickly scale up vaccines, viral vector-based
therapies, and other novel modalities.
To do so, GE Healthcare Life Sciences will work closely with
Pharmadule Morimatsu, a company specializing in the design and
manufacture of modular facilities. Pharmadule will provide
engineering design, construction, installation, and validation
services, based on GE Healthcare Life Sciences' proprietary
design.
Read more at
https://www.gelifesciences.com/en/us/news-center/ge-healthcare-life-sciences-and-pharmadule-morimatsu-collaborate-10001